Lab Budgets and Sources of Funding in 2014 - The Market Outlook for the United States, Europe and Asia

 **Single User Copy is for Print Only 

Report Scope & Objectives

Life science research is weathering an economically challenging time, exacerbated by the federal budget sequestration in the United States and by continued austerity in Europe. Grant money from all sources, both public and private, is increasingly difficult to obtain; and pharmaceutical spending on R&D has flattened following years of solid gains. Adds to this mix a decreased level of reimbursement for molecular diagnostic testing and a slow recovery from the "Great Recession" to establish the external macro economic environment that has led to a new normal that is defined by increasingly constrained budgets. 

By contrast, developing nations in Asia (China in particular) are making significant investments in higher education, with a focus on science and technology, to include biotechnology. In addition, many global pharmaceutical and biopharmaceutical firms are establishing research centers in these countries; taking advantage of lower cost structures and the new availability of a well-trained work force. Our 2013 studies suggest that average laboratory budgets in Asia are larger than those in the United States and Europe. In this complex macroeconomic environment, life science suppliers are seeking guidance as to how to anticipate market trends in the United States, Europe and Asia in 2014.

In this multi-sponsor report, BioInformatics LLC has conducted an in-depth exploration of projected lab budgets and sources of funding by region, and the implications of these findings for the life science tools market in the coming year.   

The objective of this study is to assess sources of funding, the competitive landscape and market opportunities for life science tools companies. From the perspective of end-users, the goals of this assignment will be to:

• Understand current sources of funding from government/stimulus/private foundation grants, distribution time frame and how labs initiate applications for funding.

• Compare and contrast FY2013 (actual), and FY2014 (projected) average lab budgets in total by broad product category, region and market segment; providing directional information for FY2014.

• Estimate scientists' budget for purchases and anticipated purchases in instrumentation and consumables, examining trends across key product categories.

• Assess how optimistic scientists are regarding funding and the future of life science research.



BioInformatics LLC will deliver an in-depth analysis of the study's significant findings and their implications for your 2014 marketing strategy. An electronic version (PDF) of the final report, data set and data legend will be provided to each sponsor. The final report will consist of the following sections: 

SECTION 1 - Overview and Regional Comparisons 
SECTION 2 - Market Analysis and Funding Situation for the United States 
SECTION 3 - Market Analysis for Funding Situation in Europe
SECTION 4 - Market Analysis for Asia
SECTION 5 - Study Methodology and Demographics
SECTION 6 - Verbatim Comments from Survey Respondents